Oruka Therapeutics Earnings
NASDAQ: ORKAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
82.11+4.83 (+6.25%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Oruka Therapeutics earnings summary
In its most recent report on Aug 11, 2025 (Q2 2025), ORKA posted EPS of $-0.46. Across the last 15 reports, ORKA shares moved an average of 5.5% (in either direction) in the first trading session after results, rising 6 times and falling 8 times.
Summary generated from market data by MetaCap's automated system. Methodology
ORKA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 11, 2025 | — | $-0.46 | — | +0.5% |
| May 14, 2025 | — | $-0.40 | — | +8.8% |
| Nov 13, 2024 | — | $-1.46 | — | -13.7% |
| Aug 1, 2024 | — | $-6.96 | — | -9.6% |
| Apr 25, 2024 | — | $-0.14 | — | -8.9% |
| Feb 1, 2024 | — | $-0.08 | — | +2.5% |
| Oct 18, 2023 | — | $-0.10 | — | -7.9% |
| Jul 21, 2023 | — | $-0.10 | — | 0.0% |
| Apr 24, 2023 | — | $-0.09 | — | +5.5% |
| Feb 24, 2023 | — | $-0.08 | — | +3.3% |
| Oct 28, 2022 | — | $-0.16 | — | -5.5% |
| Aug 2, 2022 | — | $-0.22 | — | +4.7% |
| May 2, 2022 | — | $-0.23 | — | -0.4% |
| Mar 14, 2022 | — | $-0.39 | — | -5.2% |
| Nov 2, 2021 | — | $-0.33 | — | -6.1% |
| Aug 4, 2021 | — | $-0.34 | — | — |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.